UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): December 22, 2006
LeMaitre Vascular, Inc.
(Exact Name of Registrant as Specified in Its Charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 001-33092 | 04-2825458 | |
| (Commission File Number) | (IRS Employer Identification No.) |
| 63 Second Avenue | ||
| Burlington, Massachusetts | 01803 | |
| (Address of Principal Executive Offices) | (Zip Code) |
(781) 221-2266
(Registrant’s Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. Departure of Directors or Principal Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
On December 22, 2006, the Compensation Committee of the Board of Directors of LeMaitre Vascular, Inc. (the “Company”) approved the following awards of the Company’s common stock under the Company’s 2006 Stock Option and Incentive Plan (the “Plan”) to the officers identified below. These awards are not subject to vesting.
| Shares | ||
| David B. Roberts, Chief Financial Officer |
11,806 | |
| Peter R. Gebauer, President, International Operations |
13,255 | |
| Kevin D. Kelly, Vice President, North American Sales |
1,363 | |
| Trent G. Kamke, Senior Vice President, Operations |
3,120 |
Also on December 22, 2006, the Compensation Committee approved the following awards of restricted stock units under the Plan to the officers identified below. These awards will vest in equal installments over a three year period based on continued service to the Company.
| Shares underlying RSUs | ||
| David B. Roberts, Chief Financial Officer |
10,000 | |
| Peter R. Gebauer, President, International Operations |
10,000 | |
| Kevin D. Kelly, Vice President, North American Sales |
5,000 | |
| Trent G. Kamke, Senior Vice President, Operations |
10,000 |
A form of restricted stock unit award agreement is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
| Exhibit Number |
Exhibit | |
| 99.1 | Form of Restricted Stock Unit Award Agreement |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| LEMAITRE VASCULAR, INC. | ||||
| Dated: December 26, 2006 | By: | /s/ Aaron M. Grossman | ||
| Name: | Aaron M. Grossman | |||
| Title: | General Counsel | |||
EXHIBIT INDEX
| Exhibit Number |
Description | |
| 99.1 | Form of Restricted Stock Unit Award Agreement |